Estadisticas : Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

Jantus-Lewintre E.
Visitas:433
296 ( Estados Unidos de América )
63 ( Singapur )
28 ( Reino Unido )
19 ( Alemania )
7 ( Hong kong )
3 ( Francia )
3 ( Finlandia )
3 ( Suecia )
2 ( China )
2 ( Letonia )
2 ( España )
2 ( Togo )
1 ( Chile )
1 ( Eslovenia )
1 ( Australia )

Descargas: 255